SCHEMBL16904875

SCHEMBL16904875

CCC1OC(OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H]1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGALS9 O00182 1/20 0.45
LGALS1 P09382 1/20 0.45
LGALS3 P17931 1/20 0.45
LGALS7; LGALS7B P47929 1/20 0.45
PTPN1 P18031 4/20 0.41
NT5E P21589 1/20 0.41
LMNA P02545 1/20 0.40
BCHE P06276 3/20 0.39
F11 P03951 1/20 0.38
CTSK P43235 1/20 0.38
SELP P16109 2/20 0.38
PTGES2 Q9H7Z7 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.37
HIF1A Q16665 1/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
PTPN2 P17706 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12150947 1.00 LGALS9 (0.45) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL26808443 1.00 LGALS9 (0.45) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL16489268 0.96 LGALS9 (0.44) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL26442408 0.96 LGALS3 (0.44) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL17773533 0.96 LGALS9 (0.44) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL10024720 0.93 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL17322467 0.93 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL15837375 0.93 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL29323260 0.93 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL17211042 0.93 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708607-B2 Modified RNAi agents ALNYLAM PHARMACEUTICALS, INC. (US) 2017-07-18 US disclosed
US-20150197746-A1 MODIFIED RNAi AGENTS ALNYLAM PHARMACEUTICALS, INC. (US) 2015-07-16 US disclosed